| For: | Neokosmidis G, Cholongitas E, Tziomalos K. Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? World J Gastroenterol 2021; 27(39): 6522-6526 [PMID: 34754150 DOI: 10.3748/wjg.v27.i39.6522] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i39/6522.htm |
| Number | Citing Articles |
| 1 |
George W. Marek, Harmeet Malhi. MetALD: Does it require a different therapeutic option?. Hepatology 2024; 80(6) doi: 10.1097/HEP.0000000000000935
|
| 2 |
Mangesh Pagadala, Sajid Jalil, Nicholas Dunn, Ashwani K. Singal. Pharmacologic management of metabolic and alcohol-associated liver disease. Metabolism and Target Organ Damage 2026; 6(2) doi: 10.20517/mtod.2026.29
|
| 3 |
Hanqi Yu, Hongfan Ding, Yang Huang, Haoze Cao, Yuan Ding, Weilin Wang. From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies. Portal Hypertension & Cirrhosis 2026; 5(2) doi: 10.1002/poh2.70036
|
| 4 |
Lu Sun, Ao Wang, Yi Zhang, Jinsi Chen, Peng Huang, Kaixuan Zeng, Shuai Huang, Jiayu Huang, Jin Luo, Jiancheng Wang. High-fat diet leads to male reproductive dysfunction by disrupting lipid-droplet-mediated organelle crosstalk. Cellular & Molecular Biology Letters 2026; 31(1) doi: 10.1186/s11658-026-00891-2
|
| 5 |
Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; doi: 10.1007/978-981-97-9519-2_10
|
| 6 |
Bo Zhu. Synergistic therapeutic strategies for metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus: molecular insights and clinical advances. Frontiers in Endocrinology 2026; 16 doi: 10.3389/fendo.2025.1753393
|
| 7 |
Pradeep Kayampilly, Nancy Roeser, Thekkelnaycke M Rajendiran, Subramaniam Pennathur, Farsad Afshinnia. Acetyl Co-A Carboxylase Inhibition Halts Hyperglycemia Induced Upregulation of De Novo Lipogenesis in Podocytes and Proximal Tubular Cells. Metabolites 2022; 12(10) doi: 10.3390/metabo12100940
|
| 8 |
Mirosław Kiedrowski. Assessment of energy balance in nutritional counseling – fact or myth?. Postępy Higieny i Medycyny Doświadczalnej 2024; 78(1) doi: 10.2478/ahem-2024-0012
|
| 9 |
Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak. Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review. Phytochemistry Reviews 2024; 23(4) doi: 10.1007/s11101-023-09912-w
|
| 10 |
Abdelilah Arredouani. Lifestyle-Related Diseases and Metabolic Syndrome. 2022; doi: 10.5772/intechopen.106445
|
| 11 |
Qin Yuan, Qianqian Zhou, Nanlan Wang, Yuancui Zheng, Hua Hu, Shiyao Hu, Huiqun Wang. Integrative proteomics and metabolomics of Guizhou Miao Sour Soup affecting simple obese rats. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1019205
|
| 12 |
Hao Yang, Lijuan Zhang, Xinle Tang. Integrated Network Pharmacology and Gut Microbiota Analysis Reveals the Alcoholic Extract of Anacyclus pyrethrum Root Prevents Nonalcoholic Fatty Liver Disease via the LPS/TLR4/NF-κB Pathway. International Journal of Molecular Sciences 2026; 27(10) doi: 10.3390/ijms27104398
|